MICRO-K LS
POTASSIUM CHLORIDE
Approval overview MICRO-K LS is listed in Drugs@FDA under application 019561 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient POTASSIUM CHLORIDE Form and strength FOR SUSPENSION, EXTENDED RELEASE;ORAL - 20MEQ/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor KV PHARM Submission history Latest submission status date: 2005-08-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview MICRO-K LS is listed in Drugs@FDA under application 019561 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient POTASSIUM CHLORIDE Form and strength FOR SUSPENSION, EXTENDED RELEASE;ORAL - 20MEQ/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor KV PHARM Submission history Latest submission status date: 2005-08-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.